Heron Therapeutics, Inc.HRTXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank7
3Y CAGR-46.8%
5Y CAGR-41.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-46.8%/yr
vs -12.3%/yr prior
5Y CAGR
-41.0%/yr
Recent deceleration
Acceleration
-34.5pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.43M | -25.5% |
| 2024 | $16.68M | -57.4% |
| 2023 | $39.13M | -52.7% |
| 2022 | $82.70M | -36.8% |
| 2021 | $130.82M | -25.0% |
| 2020 | $174.53M | +4.3% |
| 2019 | $167.38M | +19.5% |
| 2018 | $140.03M | +1.0% |
| 2017 | $138.58M | +34.4% |
| 2016 | $103.13M | - |